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In spite of the increase in the attribute of metabolic disorders to the incidence of cardiovascular disease (CVD), hypertension remains the most important risk factor in Japanese people^[@bib1],\ [@bib2])^. Hypertension accounted for more than one-third of stroke incidence in the mostly middle-aged participants of the Japan Public Health Center-based prospective (JPHC) Study^[@bib3])^. It is an established risk factor of stroke in much older individuals too^[@bib4],\ [@bib5])^. In the Suita Study, the cumulative lifetime risk of stroke at the age of 75 years was 11.8% and 13.1% for hypertensive men and women, respectively; the risk lowers to 5.5% and 5.3% for men and women without hypertension, respectively^[@bib6])^. Furthermore, it was reported in this issue of the *Journal of Atherosclerosis and Thrombosis* that hypertension was the only risk factor significantly associated with stroke incidence in individuals aged ≥ 75 years (old-old) and 60--74 years (young-old) in the Ohasama Study^[@bib7])^. These results from the observational studies^[@bib8]--[@bib16])^ together with findings of previous intervention studies^[@bib17]--[@bib20])^ confirm the appropriateness of the current hypertension guidelines for the management of hypertension for older individuals in Japan^[@bib21])^ (**[Table 1](#T1){ref-type="table"}**).

###### Recent (published in 2013 or later) epidemiological findings of blood pressure\'s association with cardiovascular disease in the older individuals

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study name, year published                                      Singapore Chinese Health Study, 2016^[@bib8])^   Costa Rican CRELES study, 2016^[@bib10])^             Northern Manhattan Study (US), 2016^[@bib9])^   Taipei City Geriatric Health Examination Database, 2015^[@bib11])^   Strobe-Compliant Study (China), 2015^[@bib12])^   Kangwha cohort study (Korea), 2015^[@bib13])^   REGARDS study (US), 2014^[@bib14])^                             TGLS Study (Iran), 2014^[@bib15])^                                            LSUHLS (US), 2013^[@bib16])^
  --------------------------------------------------------------- ------------------------------------------------ ----------------------------------------------------- ----------------------------------------------- -------------------------------------------------------------------- ------------------------------------------------- ----------------------------------------------- --------------------------------------------------------------- ----------------------------------------------------------------------------- ------------------------------------------------
  Baseline year                                                   1993--1998                                       2004--2006                                            1993--2001                                      2006                                                                 2004--2006                                        1985                                            2003--2007                                                      1999--2001                                                                    1999--2009

  Follow-up, years                                                max: 10                                          mean: 5.1                                             median: 13                                      max: 4                                                               median: 4.8                                       max: 23.8                                       median: 4.5                                                     median: 10                                                                    mean: 6.0

  Age range or mean age, years                                    48--85, 63.0 ± 7.8                               60-, 76 ± 10.2                                        60-, 72 ± 8                                     65-, 73.0                                                            60-, 69.5 ± 7.0                                   55-, 66.7 ± 8.0                                 55-, 79.3 ± 3.7 \[for those aged ≥ 75\]                         60-, 65.8                                                                     30--94

  Sample size                                                     30,692 (n of age ≥ 60 = 19,110)                  2,346                                                 1,750                                           77,389                                                               5,006                                             6,294 (n of age ≥ 65 = 3,387)                   9,787 (n of age ≥ 75 = 1,839)                                   1,845                                                                         30,154

  Inclusion criteria related to histories                         none                                             those without stroke, heart disease or cancer         those without stroke, DM, and CKD               none                                                                 those with HT                                                                                     those taking antihypertensive medications                       those without CVD                                                             DM patients without a history of CHD or stroke

  Women (%)                                                       55.7%                                            57.2%                                                 63.0%                                           49.2%                                                                51.4%                                             57.2%                                           63.1% \[for those aged ≥ 75\]                                   49.6%                                                                         64%

  Baseline SBP/DBP, mmHg                                          SBP: \<100: 2.9%\                                SBP: 140--159: 31%[\*](#tf1){ref-type="table-fn"},\   SBP: \<140: 43%,\                               Men:\                                                                SBP: 162.5 ± 21.3/DBP: 91.7 ± 12.9                SBP: 148.5 ± 31.7 \[for total sample\]          Isolated Systolic Hypertension, 25.7% \[for those aged ≥ 75\]   SBP: 136.0/DBP: 80.1                                                          SBP: 145/DBP: 80
                                                                  110--119: 20.1%,\                                ≥ 160: 21.7%[\*](#tf1){ref-type="table-fn"};\         140--149: 20%,\                                 SBP: 135.0 ± 19.0/DBP: 76.4 ± 11.5,\                                                                                                                                                                                                                                                                                 
                                                                  120--139: 35.4%,\                                DBP \<70: 17.6%[\*](#tf1){ref-type="table-fn"},\      ≥ 150: 37%                                      Women:\                                                                                                                                                                                                                                                                                                              
                                                                  140--159: 26.4%,\                                ≥ 90: 22.0%[\*](#tf1){ref-type="table-fn"}                                                            SBP: 135.7 ± 20.1/DBP: 75.8 ± 11.4                                                                                                                                                                                                                                                                                   
                                                                  160--179: 11.1%,\                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                  ≥ 180: 4.1%                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Outcome                                                         CVD mortality                                    CVD mortality                                         Stroke incidence                                CVD mortality                                                        CVD mortality, CHD and stroke incidence           CVD mortality                                   CVD incidence                                                   CVD incidence                                                                 CHD incidence

  Reference BP category                                           SBP 120--139                                     SBP \< 140                                            SBP \< 140                                      SBP \< 120 and DBP \< 80                                             SBP \< 130 DBP 85--89                             SBP: 100--119                                   SBP \< 120                                                      SBP \< 120 and DBP \< 80                                                      SBP: 130--139 and DBP: 80--89

  BP categories significantly associated with increased outcome   SBP ≥ 180;\                                      SBP ≥ 160                                             SBP 140--149                                    SBP ≥ 160 DBP ≥ 100                                                  SBP ≥ 160 DBP ≥ 100                               SBP ≥ 180 (in those aged ≥ 65)                  SBP ≥ 150 (in those aged ≥ 75)                                  SBP ≥ 140, DBP ≥ 90 or on antihypertensive medications (in those aged ≥ 60)   \< 110/65 (in those aged 60--94)
                                                                  SBP \< 100 in those with CVD history                                                                                                                                                                                                                                                                                                                                                                                                                                        
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CRELES indicates Costa Rican Longevity and Healthy Aging Study; US, United States; DM, diabetes mellitus; CKD, chronic kidney disease; HT, hypertension; SBP, systolic blood pressure; DBP, diastolic blood pressure; CVD, cardiovascular disease; CHD, coronary heart disease; BP, blood pressure.

The percentages are based on the number of total participants interviewed at baseline. Those of the analyzed sample were not available.

REGARDS indicates REasons for Geographic and Racial Differences in Stroke; TLGS, Tehran Lipid and Glucose Study; LSUHLS, Louisiana State University Hospital-Based Longitudinal Study. For the other abbreviations, please see the first page of [Table 1](#T1){ref-type="table"}.

Evidence from observational studies generally requires careful interpretation. It is judicious to use some kind of checklist when making a causal judgment^[@bib22])^. For example, diabetes was positively associated with stroke incidence in the young-old participants, but the association was not found in the old-old participants in the Ohasama Study. The authors raised a possibility of selection (bias) for this unexpected finding, i.e., those who survived to be old-old might have a resistance to the effect of diabetes on the cardiovascular system. Apart from this authors\' idea, we can discuss the issue again using the checklist (**[Table 2](#T2){ref-type="table"}**).

###### Checklist for interpreting epidemiological studies

  -------------------
  Confounding
  Reverse causation
  Measurement
  Generalizability
  -------------------

Confounding refers to a situation where the association between two variables (causal- and outcome-assumed variables) arises (becomes stronger) or diminishes (becomes weaker) under the existence of a confounding variable that is associated with both the variables. We cannot expect that all the confounding variables are always measured. A confounding variable is not a mediator; but is a factor that is generated by the causal variable and pathophysiologically affects the outcome variable by definition. In the study, nutritional condition and body habitus might have been the confounding variables if they had been related to both diabetes and stroke incidence^[@bib23],\ [@bib24])^. Another possible confounding factor is health service usage. If blood pressure of those with diabetes had been managed more carefully than those without or if they had received more preventive measures, such as aspirin, this could have confounded the association.

We present a possible scenario of reverse causation here. The subjects who were likely to develop stroke in future could have been less likely to have, be aware of, or report diabetes at baseline. With that being said, this scenario would have hardly happened.

Measurement sometimes causes misclassification. It occurs in both causal and outcome variables. In the study, diabetes was self-reported. In general, the validity of self-report at baseline is not influenced by the outcome in prospective studies. Thus, this kind of misclassification is usually called non-differential misclassification and is likely to lead to attenuation of the association toward null. An example of differential misclassification related to self-report is recall bias. Differential misclassification of the outcome variable occurs if surveillance or case definition is influenced by baseline variables. In such instances, the association between the causal and outcome variables appears stronger or weaker than in reality. In the study, the association between diabetes and stroke incidence was null (not inverse) in the old-old individuals. Inaccurate self-report on diabetes status may partly explain that finding. The authors mentioned the possibility as a study limitation that the validity of self-report on diabetes decreased as the age of the subjects increased.

Finally, can we generalize the present findings? Characterization of the studied participants was simple but comprehensive in the article. The baseline survey was conducted in 1998. The study excluded those with a history of stroke while included those with histories of heart and kidney diseases. Confounding variables, such as height and weight, and medical histories were obtained via self-reporting. This information raises the possibilities of residual confounding of health statuses at baseline and unmeasured confounding of other lifestyle factors, such as diet. However, the participation rate was satisfactory. Approximately 90% of the population agreed to participate in the study, and 80% of the population was actually analyzed. Therefore, the present findings would be generalizable to another geriatric population, like Ohasama, in spite of the possibility of residual and unmeasured confounding.
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